Muscle Health Patterns and Brain MRI Indices: A Cluster Analysis.
Muscle Health Patterns and Brain MRI Indices: A Cluster Analysis.
复制标题
DOI:
10.1093/geroni/igac073
复制
发表时间:
2023
影响因子:
7
通讯作者:
Chen, Wei-Liang
中科院分区:
文献类型:
--
作者:
Wu, Shou-En;Chen, Wei-Liang
The interplay between muscle and brain lacks a holistic approach to assess the combined effect of multiple factors. This study utilizes clustering analysis to identify muscle health patterns and their relationships with various brain magnetic resonance imaging (MRI) indices. Two hundred and seventy-five cognitively intact participants who completed brain MRI from the Health, Aging, and Body Composition Study were enrolled. Muscle health-related markers that showed significant relationship with total gray matter volume entered the cluster analysis. Subsequently, macrostructural and microstructural MRI indices were examined with analysis of variance and multiple linear regression analysis to determine significant associations with muscle health clusters. The muscle health cluster included 6 variables: age, skeletal muscle mass index, gait speed, handgrip strength, change of total body fat, and serum leptin level. Clustering method produced 3 clusters which had characteristics of obese, leptin-resistant, and sarcopenia, respectively. Brain MRI indices that revealed significant associations with the clusters included gray matter volume (GMV) in cerebellum (p < .001), superior frontal gyrus (p = .019), inferior frontal gyrus (p = .003), posterior cingulum (p = .021), vermis (p = .045), and gray matter density (GMD) in gyrus rectus (p < .001) and temporal pole (p < .001). The leptin-resistant group had most degree of reduction in GMV, whereas the sarcopenia group had most degree of reduction in GMD. The leptin-resistant and sarcopenia populations had higher risk of neuroimaging alterations. Clinicians should raise awareness on the brain MRI findings in clinical settings. Because these patients mostly had central nervous system conditions or other critical illnesses, the risk of sarcopenia as a comorbidity will substantially affect the prognosis and medical care.
登录
查看更多内容
影响因子:
120.7
作者:
Lieb, Wolfgang;Beiser, Alexa S.;Vasan, Ramachandran S.;Tan, Zaldy S.;Au, Rhoda;Harris, Tamara B.;Roubenoff, Ronenn;Auerbach, Sanford;DeCarli, Charles;Wolf, Philip A.;Seshadri, Sudha
通讯作者:
Seshadri, Sudha
影响因子:
0.7
作者:
Satow T;Komuro T;Kobayashi A
通讯作者:
Kobayashi A
影响因子:
4.2
作者:
Erickson KI;Leckie RL;Weinstein AM
通讯作者:
Weinstein AM
DOI:
10.1016/j.jamda.2019.09.001
发表时间:
2019-12-01
影响因子:
7.6
作者:
Nishita, Yukiko;Nakamura, Akinori;Arai, Hidenori
通讯作者:
Arai, Hidenori
影响因子:
3.1
作者:
Arvanitakis Z;Fleischman DA;Arfanakis K;Leurgans SE;Barnes LL;Bennett DA
通讯作者:
Bennett DA